A detailed history of Tang Capital Management LLC transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 2,946,260 shares of RPHM stock, worth $4.95 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
2,946,260
Previous 2,996,260 1.67%
Holding current value
$4.95 Million
Previous $4.52 Million 10.7%
% of portfolio
0.43%
Previous 0.55%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.34 - $1.7 $67,000 - $85,000
-50,000 Reduced 1.67%
2,946,260 $5.01 Million
Q2 2024

Aug 14, 2024

SELL
$1.51 - $1.9 $1,117 - $1,406
-740 Reduced 0.02%
2,996,260 $4.52 Million
Q1 2024

May 15, 2024

SELL
$1.59 - $1.74 $529,470 - $579,420
-333,000 Reduced 10.0%
2,997,000 $4.98 Million
Q4 2023

Feb 14, 2024

BUY
$1.34 - $8.43 $4.46 Million - $28.1 Million
3,330,000 New
3,330,000 $5.33 Million
Q4 2022

Feb 14, 2023

BUY
$1.8 - $3.52 $55,056 - $107,666
30,587 New
30,587 $71,000

Others Institutions Holding RPHM

About Reneo Pharmaceuticals, Inc.


  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.